Edition:
India

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

67.50CHF
18 May 2018
Change (% chg)

CHF-0.15 (-0.22%)
Prev Close
CHF67.65
Open
CHF67.75
Day's High
CHF67.75
Day's Low
CHF67.15
Volume
46,935
Avg. Vol
110,236
52-wk High
CHF74.00
52-wk Low
CHF53.05

Chart for

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 1.16
Market Cap(Mil.): CHF3,731.19
Shares Outstanding(Mil.): 55.40
Dividend: 2.75
Yield (%): 4.08

Financials

BRIEF-BB Biotech Q1 Profit Of CHF 28 Mln

* DGAP-ADHOC: BB BIOTECH SHARE GAINS VALUE IN FIRST QUARTER 2018 - SEVERAL LARGE-CAP BIOTECH COMPANIES TRADING AT WELL BELOW FUNDAMENTAL VALUE

20 Apr 2018

BRIEF-BB Biotech FY Net Result Turns to Profit Of CHF 688 Million

* FY NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN IN PREVIOUS PERIOD

16 Feb 2018

BRIEF-BB Biotech to propose 3.30 Sfr dividend for 2017

* SHOWS A DOUBLE-DIGIT TOTAL RETURN FOR 2017 - MID CAPS OVERDELIVER ON INNOVATION AND ARE BECOMING A KEY UPSIDE TRIGGER

19 Jan 2018

BRIEF-BB Biotech Reports 5.6% Passive Stake In Voyager Therapeutics

* BB BIOTECH AG REPORTS 5.6% PASSIVE STAKE IN VOYAGER THERAPEUTICS AS OF JAN 3 - SEC FILING‍​ Source text: (http://bit.ly/2CZEeZD) Further company coverage:

10 Jan 2018

Earnings vs. Estimates